Clinical Trial Update: Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial update for KPCXM18 injection in acute ischemic stroke; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• KPCXM18 Injection

Snippet

Sponsor: Kunming Pharmaceuticals, Inc. | Conditions: Acute Ischemic Stroke | Phase 2 | Status: UNKNOWN